Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14751 - 14775 of 14840 in total
PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational
Experimental
Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Investigational
BMS-986141 is under investigation in clinical trial NCT02985632 (A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants).
Investigational
GSI-136 has been used in trials studying the treatment of Alzheimer Disease.
Investigational
A phosphodiesterase inhibitor with antidepressant properties.
Investigational
Experimental
Etamivan (INN) or ethamivan (USAN) is marketed under the name Analepticon. Etamvin is a respiratory stimulant drug similar to nikethamide. It is no longer used in the United States.
Withdrawn
PF-4191834 has been investigated for the basic science of Asthma.
Investigational
Vestipitant has been investigated for the treatment of Tinnitus.
Investigational
Doramapimod is a P38 MAP kinase inhibitor.
Investigational
Displaying drugs 14751 - 14775 of 14840 in total